The Japanese Journal of Gastroenterological Surgery
Online ISSN : 1348-9372
Print ISSN : 0386-9768
ISSN-L : 0386-9768
The Effect of Lentinan on the Immunological Changes after Operation for Esophageal Cancer
Satoru HayashiMasayuki MatsumoriMasayoshi Okada
Author information
JOURNAL FREE ACCESS

1993 Volume 26 Issue 7 Pages 1921-1928

Details
Abstract

The host defense mechanism in patients with esophageal cancer is markedly suppressed by surgical intervention in the presence of malignant tumor and malnutrition. In has been shown to cause a higher incidence of postoperative infection, and damages the tolerance for recurrence of the tumor. The immunological changes before and after surgery in 33 patients who underwent surgery for esophageal cancer was studied. Parameters such as blood leukocyte count (WBC), blood lymphocyte count, immunoglobulins (IgG, IgA), subsets of lymphocytes (Leu. 4, Leu. 3a, Leu. 2a, Leu. 7, Leu. 11), antibody-dependent cell-mediated cytotoxicity (ADCC), and natural killer (NK) activity were routinely measured. The effect of Lentinan on the immune response of patients after surgery was also evaluated. Lentinan was intravenously administrated at 2 mg every week to 18 of 33 patients from two weeks before the operation. Parameters such as total lymphocytes, IgG, IgA, CH50, Leu. 4, Leu. 3a/Leu. 2a, ADCC and NK activity were suppressed after surgery. Cell-mediated immunity (Leu. 3a/Leu. 2a, ADCC and NK activity) was further depressed and it remained so longer. The suppression of total lymphocytes, Leu. 3a/Leu. 2a, ADCC, NK activity and incidence of postoperative leukocytosis were less in the Lentinan-administrated group. The use of Lentinan was suggested to be feasible for immunity after esophageal surgery.

Content from these authors

この記事はクリエイティブ・コモンズ [表示 - 非営利 4.0 国際]ライセンスの下に提供されています。
https://creativecommons.org/licenses/by-nc/4.0/deed.ja
Previous article Next article
feedback
Top